(Credit-Canva)
The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.
Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.
Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.
Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.
Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.
Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.
Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.
According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.
All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.
Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.
Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.
Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.
People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.
Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.
Credits: Wikimedia Commons
President Trump on Thursday launched The Great Healthcare Plan, a health care proposal that outlined a set of cost-cutting ideas. The White House website reads: "President Donald J. Trump is calling on Congress to enact the Great Healthcare Plan, a comprehensive plan to lower drug prices, lower insurance premiums, hold big insurance companies accountable, and maximize price transparency."
In terms of lowering the price, prescribed drugs make it to the list, along with insurance premiums. Furthermore, the plan also states "holding big insurance companies accountable" and "maximize price transparency" as the features it will be introducing soon.
This allows lower prescription prices for all Americans by "codifying the Trump Administration's Most-Favored-Nation deals" to get Americans the same low prices for prescription drugs that people in other countries pay. This had already been introduced before on President's personal website, TrumpRx. On its launch, Trump signed deals with popular weight loss companies to lower their weight loss drug prices.
This initiative will further allow more over the counter medicines to be available at a cheaper rate. The website mentions that this will lower healthcare cost and increase "consumer choice by strengthening price transparency, increasing competition, and reducing the need for costly and time consuming doctor’s visits".
This feature includes three things:
So, what do these mean? The first feature means that the plan aims to stop sending big insurance companies billions in extra taxpayer-funded subsidy payments. Instead, money will be sent directly to eligible Americans to allow them to buy the health insurance of their choice.
The second feature includes a cost-sharing reduction program for healthcare plans which would save taxpayers at least $36 billion and reduce the most common Obamacare plan premiums by over 10%.
Lastly, the plan aims to end kickbacks from pharmacy benefit managers to the large brokerage middlemen that deceptively raise the cost of health insurance.
The first feature 'Create the “Plain-English Insurance” Standard' means that it will require health insurance companies to publish rate and coverage comparison upfront on their websites in "plain English - not industry jargon". This will be done so that consumers can make better insurance purchasing decisions.
The plan will also require health insurance companies to publish the percentage of their revenues that are paid out to claims versus overhead costs and profits on their websites.
Lastly, it will require health insurers to publish the percentage of insurance claims they reject and average wait times for routine care on their websites.
The plan would require any healthcare provider or insurer who accepts either Medicare or Medicaid to
publicly and prominently post their pricing and fees to avoid surprise medical bills.
Earlier, polls have found that many voters were unhappy with the rising health care premiums and lawmakers' inability to reach a deal on ACA subsidies. This lapse led to a spike in health-insurance cost of millions of marketplace enrollees.
“There’ll be ongoing conversations, and we hope to be able to support with specific language for the legislation,” Mehmet Oz, one of Trump’s top health care deputies, told reporters Thursday on a conference call.
Credits: AI Generated
Japanese researchers have developed a new form of wearable health technology that could reshape how illness is detected. The innovation takes the form of a “living skin” implant that emits a green glow when the body begins to show early signs of disease. Designed to sit within the skin, the implant offers a visible warning when internal health markers shift, potentially alerting users before symptoms become obvious.
The implant works by monitoring internal biomarkers, which are proteins linked to inflammation, stress, and disease processes. When these biomarkers move outside their normal range, the implant responds by glowing green. Rather than depending on a smartwatch or fitness tracker, this approach would allow people to see changes in their health directly on their skin, offering continuous feedback throughout the day and night.
The project was developed by scientists from Tokyo City University and the University of Tokyo, with technical support from engineers at RIKEN and Canon Medical Systems. The team has already tested the concept in mice, where the implant functioned as a living sensor display embedded in the skin.
The research was also featured in the Daily Star as part of The Weird Science Drop newsletter, which highlighted a range of unusual scientific developments alongside this project.
One of the most striking aspects of the implant is what it does not need. The sensor is made from living epidermal stem cells, allowing it to survive through the skin’s natural regeneration process. Because it is maintained by the body itself, the implant does not require batteries or external power sources, as per Express UK.
Professor Fujita noted that this makes the technology fundamentally different from traditional devices. “Unlike conventional devices that require power sources or periodic replacement, this system is biologically maintained by the body itself,” he said. In laboratory experiments, the sensor remained functional for more than 200 days, with the engineered stem cells continuously renewing the skin while keeping the implant active.
As per Express UK, while the technology is still being tested, the researchers believe its applications could extend well beyond human healthcare. They suggest it may be especially useful in animal research and veterinary medicine. Since animals cannot describe how they feel, a visible signal on the skin could help detect illness earlier and allow for faster intervention.
Although the implant is not yet ready for everyday use, it offers a glimpse into a future where health monitoring becomes part of the body itself, quietly working in the background and providing clear visual cues when something is not right.
Credits: Canva
Specialty chocolate bars are being removed from store shelves after concerns were raised about possible salmonella contamination, the US Food and Drug Administration said on January 12. Spring & Mulberry has announced a voluntary recall of its Mint Leaf Date-Sweetened Chocolate Bar, which has been sold online and at selected retail locations across the country since September, the FDA confirmed.
The issue was flagged during routine testing carried out by an independent laboratory. So far, no illnesses or negative health effects linked to the product have been reported.
As per The Independent, consumers who purchased the recalled chocolate are being advised to throw it away and seek a refund from Spring & Mulberry. The company has asked customers to contact them directly and provide a photograph of the chocolate bar showing the affected lot code.
A well-known chocolate brand has issued a recall after possible salmonella contamination was detected. Spring & Mulberry, a Raleigh, North Carolina-based company, voluntarily recalled its Mint Leaf Date-Sweetened Chocolate Bar following routine third-party testing that found traces of salmonella, according to an FDA notice released Monday.
The recalled bars have been sold online and through selected retail partners since September 15, 2025. Consumers can identify the affected product by its teal-colored packaging and the lot code 025255 printed on the back of the box and the inner wrapper.
Symptoms usually appear between six hours and six days after exposure. While most people recover within four to seven days, those at higher risk, including children under 5 and adults over 65, may develop more severe illness that requires medical care or hospitalization.
The recalled Spring & Mulberry chocolate carries the lot code #025255. This code applies specifically to the Mint Leaf Date-Sweetened Chocolate Bar that has been pulled from the market due to the potential risk of salmonella contamination identified during routine lab testing.
Shoppers are urged to check their packaging carefully for the listed lot code. Anyone who has a bar with the affected code should not eat it. Instead, they should discard the product and contact Spring & Mulberry to request a refund.
As per USA TODAY, although no illnesses have been reported so far, the recall has been issued as a precaution to safeguard public health, especially for vulnerable groups such as children, older adults, and people with compromised immune systems. The FDA has shared further guidance on recall steps and salmonella symptoms.
The chocolate recall follows another FDA action just months earlier involving Doughy Chocolate Chip Cookie Dough produced by Hudson River Foods in November, also due to possible salmonella contamination. That recall was later upgraded to a Class I recall on December 5 after officials determined that consuming the product could result in serious health effects or death.
A total of 113 units of the edible cookie dough were included in that recall. The affected products were sold in 12-ounce containers and carried a best-by date of July 4, 2026.
© 2024 Bennett, Coleman & Company Limited